Published in Mol Oral Microbiol on July 24, 2014
Polymicrobial synergy and dysbiosis in inflammatory disease. Trends Mol Med (2014) 1.27
The enduring importance of animal models in understanding periodontal disease. Virulence (2015) 0.87
FOXO responses to Porphyromonas gingivalis in epithelial cells. Cell Microbiol (2015) 0.79
Membrane-permeabilizing activity of reverse-amide 2-aminoimidazole antibiofilm agents against Acinetobacter baumannii. Curr Drug Deliv (2015) 0.77
New approaches to combat Porphyromonas gingivalis biofilms. J Oral Microbiol (2017) 0.77
Going beyond the Control of Quorum-Sensing to Combat Biofilm Infections. Antibiotics (Basel) (2016) 0.77
Natural antigenic differences in the functionally equivalent extracellular DNABII proteins of bacterial biofilms provide a means for targeted biofilm therapeutics. Mol Oral Microbiol (2016) 0.75
Defining the normal bacterial flora of the oral cavity. J Clin Microbiol (2005) 15.75
Prevalence of periodontitis in adults in the United States: 2009 and 2010. J Dent Res (2012) 5.57
Attachment of Bacteroides melaninogenicus subsp. asaccharolyticus to oral surfaces and its possible role in colonization of the mouth and of periodontal pockets. Infect Immun (1978) 5.20
Low-abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement. Cell Host Microbe (2011) 5.06
Bacteriological studies of developing supragingival dental plaque. J Periodontal Res (1977) 3.38
Beyond the red complex and into more complexity: the polymicrobial synergy and dysbiosis (PSD) model of periodontal disease etiology. Mol Oral Microbiol (2012) 2.82
Autoinducer 2: a concentration-dependent signal for mutualistic bacterial biofilm growth. Mol Microbiol (2006) 2.43
Dental plaque formation. Microbes Infect (2000) 2.33
A novel mouse model to study the virulence of and host response to Porphyromonas (Bacteroides) gingivalis. Infect Immun (1991) 2.07
Short fimbriae of Porphyromonas gingivalis and their role in coadhesion with Streptococcus gordonii. Infect Immun (2005) 1.91
Role of the Streptococcus gordonii SspB protein in the development of Porphyromonas gingivalis biofilms on streptococcal substrates. Microbiology (2002) 1.77
Involvement of Porphyromonas gingivalis fimbriae in adherence to Streptococcus gordonii. Oral Microbiol Immunol (1993) 1.70
Environmental regulation of fimbrial gene expression in Porphyromonas gingivalis. Infect Immun (1997) 1.55
Small molecule control of bacterial biofilms. Org Biomol Chem (2012) 1.51
Streptococcus gordonii utilizes several distinct gene functions to recruit Porphyromonas gingivalis into a mixed community. Mol Microbiol (2006) 1.47
Breaking bad: manipulation of the host response by Porphyromonas gingivalis. Eur J Immunol (2014) 1.47
Progression of chronic periodontitis can be predicted by the levels of Porphyromonas gingivalis and Treponema denticola in subgingival plaque. Oral Microbiol Immunol (2009) 1.46
Epidemiology and risk factors of periodontal diseases. Dent Clin North Am (2005) 1.46
Glyceraldehyde-3-phosphate dehydrogenase of Streptococcus oralis functions as a coadhesin for Porphyromonas gingivalis major fimbriae. Infect Immun (2004) 1.35
Porphyromonas gingivalis genes involved in community development with Streptococcus gordonii. Infect Immun (2006) 1.27
Structural dissection and in vivo effectiveness of a peptide inhibitor of Porphyromonas gingivalis adherence to Streptococcus gordonii. Infect Immun (2010) 1.26
Structural characterization of peptide-mediated inhibition of Porphyromonas gingivalis biofilm formation. Infect Immun (2006) 1.24
A regulation cascade controls expression of Porphyromonas gingivalis fimbriae via the FimR response regulator. Mol Microbiol (2004) 1.23
Microbial interactions in building of communities. Mol Oral Microbiol (2012) 1.22
The pathogenic persona of community-associated oral streptococci. Mol Microbiol (2011) 1.21
Distinct roles of long/short fimbriae and gingipains in homotypic biofilm development by Porphyromonas gingivalis. BMC Microbiol (2009) 1.20
A Porphyromonas gingivalis tyrosine phosphatase is a multifunctional regulator of virulence attributes. Mol Microbiol (2008) 1.16
A 2-aminobenzimidazole that inhibits and disperses gram-positive biofilms through a zinc-dependent mechanism. J Am Chem Soc (2009) 1.11
Inhibition and dispersion of Pseudomonas aeruginosa biofilms with reverse amide 2-aminoimidazole oroidin analogues. Org Biomol Chem (2008) 1.10
Construction and screening of a 2-aminoimidazole library identifies a small molecule capable of inhibiting and dispersing bacterial biofilms across order, class, and phylum. Angew Chem Int Ed Engl (2008) 1.09
Subgingival biofilm formation. Periodontol 2000 (2010) 1.09
A new small molecule specifically inhibits the cariogenic bacterium Streptococcus mutans in multispecies biofilms. Antimicrob Agents Chemother (2011) 1.08
Porphyromonas gingivalis short fimbriae are regulated by a FimS/FimR two-component system. FEMS Microbiol Lett (2007) 1.00
Identification of a two-component signal transduction system involved in fimbriation of Porphyromonas gingivalis. Microbiol Immunol (2000) 0.99
Community signalling between Streptococcus gordonii and Porphyromonas gingivalis is controlled by the transcriptional regulator CdhR. Mol Microbiol (2010) 0.97
Transcriptional organization of the Porphyromonas gingivalis fimA locus. FEMS Microbiol Lett (2007) 0.90
Deep sequencing of Porphyromonas gingivalis and comparative transcriptome analysis of a LuxS mutant. Front Cell Infect Microbiol (2012) 0.89
Small-molecule inhibition of bacterial two-component systems to combat antibiotic resistance and virulence. Future Med Chem (2013) 0.88
Characterization of a bacterial tyrosine kinase in Porphyromonas gingivalis involved in polymicrobial synergy. Microbiologyopen (2014) 0.87
Role of gallium and silver from phosphate-based glasses on in vitro dual species oral biofilm models of Porphyromonas gingivalis and Streptococcus gordonii. Acta Biomater (2012) 0.80
miR-21-mediated tumor growth. Oncogene (2006) 9.90
Fabrication of microfluidic systems in poly(dimethylsiloxane). Electrophoresis (2000) 9.45
Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR. Proc Natl Acad Sci U S A (2001) 6.99
Negative regulation of neural stem/progenitor cell proliferation by the Pten tumor suppressor gene in vivo. Science (2001) 6.84
Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target. Proc Natl Acad Sci U S A (2006) 6.33
A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type. Genes Dev (1998) 5.14
PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway. Proc Natl Acad Sci U S A (1999) 4.90
Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis. Cell (1998) 4.77
The three-dimensional structure of canine parvovirus and its functional implications. Science (1991) 3.87
A protein encoded within the Down syndrome critical region is enriched in striated muscles and inhibits calcineurin signaling. J Biol Chem (2000) 3.26
Beyond the red complex and into more complexity: the polymicrobial synergy and dysbiosis (PSD) model of periodontal disease etiology. Mol Oral Microbiol (2012) 2.82
Fabrication of topologically complex three-dimensional microfluidic systems in PDMS by rapid prototyping. Anal Chem (2000) 2.81
Structural basis for self-association and receptor recognition of human TRAF2. Nature (1999) 2.74
Local chemokine paralysis, a novel pathogenic mechanism for Porphyromonas gingivalis. Infect Immun (1998) 2.71
Genetic deletion of the Pten tumor suppressor gene promotes cell motility by activation of Rac1 and Cdc42 GTPases. Curr Biol (2000) 2.67
Correlation of the highest-energy cosmic rays with nearby extragalactic objects. Science (2007) 2.57
N-acylhomoserine-lactone-mediated communication between Pseudomonas aeruginosa and Burkholderia cepacia in mixed biofilms. Microbiology (2001) 2.51
Structural basis of caspase inhibition by XIAP: differential roles of the linker versus the BIR domain. Cell (2001) 2.43
Type III collagen is crucial for collagen I fibrillogenesis and for normal cardiovascular development. Proc Natl Acad Sci U S A (1997) 2.37
Dental plaque formation. Microbes Infect (2000) 2.33
A targeted mutation at the known collagenase cleavage site in mouse type I collagen impairs tissue remodeling. J Cell Biol (1995) 2.30
Binding of peptides with basic residues to membranes containing acidic phospholipids. Biophys J (1991) 2.30
Role of fimbriae in Porphyromonas gingivalis invasion of gingival epithelial cells. Infect Immun (1997) 2.27
Streptococcal adhesion and colonization. Crit Rev Oral Biol Med (1997) 2.27
The structural basis for the recognition of diverse receptor sequences by TRAF2. Mol Cell (1999) 2.25
In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol (1998) 2.23
Characterization of human influenza virus variants selected in vitro in the presence of the neuraminidase inhibitor GS 4071. Antimicrob Agents Chemother (1998) 2.19
Morphometric and electron-microscopic analyses of the effects of gonadotropin-releasing hormone agonists on uterine leiomyomas. Arch Pathol Lab Med (1998) 2.11
Trisomy eight in ES cells is a common potential problem in gene targeting and interferes with germ line transmission. Dev Dyn (1997) 2.05
Intra- and interspecies regulation of gene expression by Actinobacillus actinomycetemcomitans LuxS. Infect Immun (2001) 1.97
Acute renal failure requiring dialysis after percutaneous coronary interventions. Catheter Cardiovasc Interv (2001) 1.93
Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer. Clin Cancer Res (2001) 1.93
Changing prevalence of tuberculosis infection with increasing age in high-burden townships in South Africa. Int J Tuberc Lung Dis (2010) 1.92
The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation. J Am Coll Cardiol (1998) 1.91
Signaling system in Porphyromonas gingivalis based on a LuxS protein. J Bacteriol (2001) 1.87
PTEN regulates the ubiquitin-dependent degradation of the CDK inhibitor p27(KIP1) through the ubiquitin E3 ligase SCF(SKP2). Curr Biol (2001) 1.86
Longitudinal study of brain morphology in first episode schizophrenia. Biol Psychiatry (2001) 1.86
Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist. J Clin Invest (1997) 1.86
TNF-alpha stimulates activation of pro-MMP2 in human skin through NF-(kappa)B mediated induction of MT1-MMP. J Cell Sci (2001) 1.76
Identification of a Streptococcus gordonii SspB domain that mediates adhesion to Porphyromonas gingivalis. Infect Immun (1997) 1.76
Cloning and expression of a Streptococcus sanguis surface antigen that interacts with a human salivary agglutinin. Infect Immun (1988) 1.75
Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs. Am J Psychiatry (1994) 1.72
High-cooperativity coupling of electron-spin ensembles to superconducting cavities. Phys Rev Lett (2010) 1.69
Plk3 functionally links DNA damage to cell cycle arrest and apoptosis at least in part via the p53 pathway. J Biol Chem (2001) 1.66
Biofilm formation by Porphyromonas gingivalis and Streptococcus gordonii. J Periodontal Res (1998) 1.65
Detection of mecA, femA, and femB genes in clinical strains of staphylococci using polymerase chain reaction. Epidemiol Infect (1994) 1.64
Molecular basis for CD40 signaling mediated by TRAF3. Proc Natl Acad Sci U S A (2000) 1.64
Orbital frontal and amygdala volume reductions in obsessive-compulsive disorder. Arch Gen Psychiatry (1999) 1.61
Genetically defined mouse models that mimic natural aspects of human prostate cancer development. Endocr Relat Cancer (2004) 1.61
Intergeneric communication in dental plaque biofilms. J Bacteriol (2000) 1.61
PTEN and GSK3beta: key regulators of progression to androgen-independent prostate cancer. Oncogene (2006) 1.59
NAMPT overexpression in prostate cancer and its contribution to tumor cell survival and stress response. Oncogene (2010) 1.58
Morphology of single olivocerebellar axons labeled with biotinylated dextran amine in the rat. J Comp Neurol (1999) 1.57
Identification of a novel pathway important for proliferation and differentiation of primary erythroid progenitors. Proc Natl Acad Sci U S A (1997) 1.57
Scavenger receptor A gene regulatory elements target gene expression to macrophages and to foam cells of atherosclerotic lesions. Proc Natl Acad Sci U S A (1995) 1.56
Environmental regulation of fimbrial gene expression in Porphyromonas gingivalis. Infect Immun (1997) 1.55
Hepatitis C seroprevalence among newly incarcerated inmates in the Texas correctional system. Public Health (2003) 1.55
Actinobacillus actinomycetemcomitans fimbriae. Oral Microbiol Immunol (1988) 1.55
Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes. Diabetologia (2012) 1.55
Valproic acid therapy in childhood epilepsy. JAMA (1980) 1.54
Dynamics of human immunodeficiency virus type 1 replication in vertically infected infants. J Virol (1999) 1.54
Mesohepatectomy for centrally located liver tumours. Br J Surg (2013) 1.53
Cytokine receptor signal transduction and the control of hematopoietic cell development. Annu Rev Cell Dev Biol (1996) 1.53
Fluorescence image analysis of the association between Porphyromonas gingivalis and gingival epithelial cells. Cell Microbiol (1999) 1.52
In vivo expression of the novel CXC chemokine BRAK in normal and cancerous human tissue. Am J Pathol (2000) 1.51
Phase-sensitive optical time-domain reflectometry with Brillouin amplification. Opt Lett (2014) 1.51
Covalent inhibition revealed by the crystal structure of the caspase-8/p35 complex. Nature (2001) 1.51
Transforming growth factor-beta - and tumor necrosis factor-alpha -mediated induction and proteolytic activation of MMP-9 in human skin. J Biol Chem (2001) 1.48
Inhibition of epithelial cell apoptosis by Porphyromonas gingivalis. FEMS Microbiol Lett (2001) 1.47
The role of lipoprotein processing by signal peptidase II in the Gram-positive eubacterium bacillus subtilis. Signal peptidase II is required for the efficient secretion of alpha-amylase, a non-lipoprotein. J Biol Chem (1999) 1.45
Miz1, a novel zinc finger transcription factor that interacts with Msx2 and enhances its affinity for DNA. Mech Dev (1997) 1.45
D-Alanine substitution of teichoic acids as a modulator of protein folding and stability at the cytoplasmic membrane/cell wall interface of Bacillus subtilis. J Biol Chem (2000) 1.44
Structural predictions for the ligand-binding region of glycoprotein hormone receptors and the nature of hormone-receptor interactions. Structure (1995) 1.42
Sensory but not motor neuron deficits in mice lacking NT4 and BDNF. Nature (1995) 1.41
The association of glutathione S-transferase polymorphisms in patients with osteosarcoma: evidence from a meta-analysis. Eur J Cancer Care (Engl) (2014) 1.41
Discrete protein determinant directs the species-specific adherence of Porphyromonas gingivalis to oral streptococci. Infect Immun (2001) 1.41
Acute type 5 phosphodiesterase inhibition with sildenafil enhances flow-mediated vasodilation in patients with chronic heart failure. J Am Coll Cardiol (2000) 1.40
Interleukin 1alpha (IL-1alpha) induced activation of p38 mitogen-activated protein kinase inhibits glucocorticoid receptor function. Mol Psychiatry (2004) 1.40
Reactive oxygen species-induced phosphorylation of p53 on serine 20 is mediated in part by polo-like kinase-3. J Biol Chem (2001) 1.39
Sequence-specific recognition of DNA in the nucleosome by pyrrole-imidazole polyamides. J Mol Biol (2001) 1.39
Heart rate turbulence in masked hypertension and white-coat hypertension. Eur Rev Med Pharmacol Sci (2015) 1.38
Cell-specific expression of the macrophage scavenger receptor gene is dependent on PU.1 and a composite AP-1/ets motif. Mol Cell Biol (1994) 1.37
Cloning, expression, and pharmacological characterization of a novel human histamine receptor. Mol Pharmacol (2001) 1.34
Relationships between antiviral treatment effects and biphasic viral decay rates in modeling HIV dynamics. Math Biosci (1999) 1.34
Real time TaqMan PCR detection and quantitation of HBV genotypes A-G with the use of an internal quantitation standard. J Clin Virol (2004) 1.34
Hippocampal/amygdala volumes in geriatric depression. Psychol Med (1999) 1.33
Interbacterial binding among strains of pathogenic and commensal oral bacterial species. Oral Microbiol Immunol (1996) 1.33
Absence of BRAF mutations in UV-protected mucosal melanomas. J Med Genet (2004) 1.32
NAC1 modulates sensitivity of ovarian cancer cells to cisplatin by altering the HMGB1-mediated autophagic response. Oncogene (2011) 1.32
Structure-activity relationship studies of novel carbocyclic influenza neuraminidase inhibitors. J Med Chem (1998) 1.30
Morphological variety of the soft palate in normal individuals: a digital cephalometric study. Dentomaxillofac Radiol (2008) 1.28
Efficient lipid production with Trichosporon fermentans and its use for biodiesel preparation. Bioresour Technol (2008) 1.27
Evidence for an improvement in cognitive function following treatment of Schistosoma japonicum infection in Chinese primary schoolchildren. Am J Trop Med Hyg (1999) 1.26
GSK3 beta mediates suppression of cyclin D2 expression by tumor suppressor PTEN. Oncogene (2006) 1.24
Efg1, a morphogenetic regulator in Candida albicans, is a sequence-specific DNA binding protein. J Bacteriol (2001) 1.24
Antibodies to human heat-shock protein 60 are associated with the presence and severity of coronary artery disease: evidence for an autoimmune component of atherogenesis. Circulation (2001) 1.24
Different collagenase gene products have different roles in degradation of type I collagen. J Biol Chem (1996) 1.23
Fibronectin binding site in type I collagen regulates fibronectin fibril formation. J Cell Biol (1993) 1.23
MicroRNA-101-mediated Akt activation and estrogen-independent growth. Oncogene (2010) 1.23